Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' (Deficit) Equity

v3.22.4
Consolidated Statements of Changes in Shareholders' (Deficit) Equity - USD ($)
Series1 Convertible Preferred Shares
Common Shares
Additional Paid-in Capital
Accumulated other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020     $ 51,655,168 $ (50,731) $ (52,401,095) $ (796,658)
Balance at the beginning (in shares) at Dec. 31, 2020   4,828,846        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of special warrants (in shares)   270,326        
Issuance of common shares, net of issuance costs     15,868,381     15,868,381
Issuance of common shares, net of issuance costs (in shares)   2,096,357        
Share-based compensation     515,629     515,629
Foreign currency translation       (137,188)   (137,188)
Net loss         (9,790,106) (9,790,106)
Balance at the end at Dec. 31, 2021     68,039,178 (187,919) (62,191,201) $ 5,660,058
Balance at the end (in shares) at Dec. 31, 2021   7,195,529       7,195,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares, net of issuance costs     4,974,253     $ 4,974,253
Issuance of common shares, net of issuance costs (in shares)   1,383,755        
Share-based compensation     487,630     487,630
Conversion of convertible debt and derivative liability to Series 1 Convertible Preferred Shares     5,600,000     5,600,000
Conversion of convertible debt and derivative liability to Series 1 Convertible Preferred Shares (in shares) 70,000,000          
Foreign currency translation       (7,450)   (7,450)
Net loss         (18,062,263) (18,062,263)
Balance at the end at Dec. 31, 2022     $ 79,101,061 $ (195,369) $ (80,253,464) $ (1,347,772)
Balance at the end (in shares) at Dec. 31, 2022 70,000,000 8,579,284       8,579,284